“Cooking on High”: What You Need to Know about the Marijuana-Based Cooking Show’s Cast & Plot!
The name of this new Netflix cooking show is pretty much self-explanatory, but without knowing what it’s about, some may not get the clever pun. Cooking on High is a cooking show like Iron Chef or Top Chef, but with one major difference. Here are more facts about Cooking on High, which will premiere on June 22, 2018, only on Netflix! Cooking on High might sound like a peculiar name, but the show is all about being blunt! Hosted by popular YouTuber and comedian Josh Leyva, this au courant cooking show aims to pave the way for a whole new generation of crispy new cooking shows laced with ganja!
With marijuana becoming legal in more and more places, a new style of cooking is taking over. Here are some things you can expect from the show, including facts about Cooking on High’s cast. Marijuana expert and stand-up comedian Ngaio Bealum has some seriously insane knowledge about weed, and he is a cast member on Netflix’s new show! The chefs competing are ready to whip out some cool new dishes to impress the judges, and Bealum is going to guide them about what they might be cooking with. Although everyone is going to be in the rasta mood on the show, don’t forget that it is still a competition after all!
Chefs from across the nation, who are serious in making cannabis a cooking ingredient, are going to make sure they put their best plate forward. While Cooking on High’s judges are getting baked, they have a very critical task of rating the dishes, too! While there may have been shows in the past that have promoted cannabis-based cuisine, Cooking on High is probably going to be a pioneer of its kind. Heather Pasternak: The actress, writer, and comedian has performed stand-up on The Late Show with Stephen Colbert and is also known for the movies, Before You and Two Sisters. He is the creator of Highly Seasoned, a show on BREALTV, where viewers can get easy-to-make recipes using ganja to create culinary masterpieces.
Blunt talk: Medical marijuana takes root
Others worry that medical marijuana spells trouble of a different sort and is really just a smoke screen enabling full-blown recreational marijuana legalization to take root. Even as marijuana research continues to proliferate, public attitudes about its use and potential medical applications have undergone a seismic shift. In a 2017 CBS poll, 88 percent of respondents favored approving medical marijuana and 61 percent thought recreational use should be legal. Another study, conducted this year by Yahoo News and The Marist Poll, found that 83 percent of participants supported legalizing medical marijuana and 49 percent favored ending the ban on recreational use. The shift in attitudes toward marijuana and concurrent explosion of opioid abuse have left citizens and policymakers alike scratching their heads over an apparent paradox.
A 2017 study published in the journal Drug and Alcohol Dependence reported a 23 percent decrease in opioid dependence and a 13 percent drop in opioid-related overdoses in states with legal marijuana. Based on his experience, says Parks, he decided to join the fight for legalizing medical marijuana in North Carolina. Asked about the local VA Medical Center’s marijuana policies, public affairs officer Armenthis Lester explained that since the drug is illegal under federal law, VA physicians can neither prescribe nor conduct research with it. Despite its apparent promise, medical marijuana also carries risks. Regardless of where people stand on the issue, most of the folks Xpress spoke with believe legalizing medical marijuana is really only a question of when, not if.
Still, Kight, whose cancer is now in remission, wants more people to know about how helpful marijuana can be for chemotherapy patients. Whether we’re talking about medical marijuana, opioids or any other drug, patients need to do their own research and ask questions about their treatment regimen, says Hall.
This comes with very strict requirements for researchers who want to study CBD, which means that few get to actually do that work. Much of the CBD oil you can currently buy online is actually derived from imported hemp, which also contains CBD in smaller amounts, says Reiman. A 2014 Cochrane review found four clinical trials looking into the antiepileptic effects of CBD. According to the review, all the studies were pretty low-quality, so the review’s authors concluded there wasn’t enough evidence to recommend CBD for the treatment of seizures just yet. By now Epidiolex, a CBD-based oil manufactured by GW Pharmaceuticals, has received orphan drug status for the treatment of Dravet and Lennox-Gastaut syndromes, which both cause severe, treatment-resistant childhood seizures.
They’ve been allowed to give Epidiolex to about 200 people as part of a pilot program. For desperate parents who are already spending upwards of $600 a month buying highly concentrated CBD oil online, this could be a huge improvement. The results of the recent pilot study were promising, and there are now two double-blind Epidiolex trials underway. Because Epidiolex is derived from the marijuana plant, it is still considered a Schedule I drug during the trial phase. While CBD may provide relief for those suffering from seizures, evidence for the compound’s other potential uses is a little more complicated.
Research has shown that patients with inflammatory bowel disease may find relief with medical marijuana, but find the psychoactive effects limiting. A 2012 double-blind, placebo-controlled trial began to do just that, but so far results are inconclusive. Another GW Pharmaceuticals phase-2 trial that examined the treatment of diabetes with marijuana turned out negative – no significant differences between the treatment and control groups.